- AU$33.24m
- AU$23.17m
- NZ$59.41m
- 74
- 74
- 60
- 76
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 24.6 | 27.7 | 31.3 | 55.9 | 59.4 |
Cost of Revenue | |||||
Gross Profit | 13.4 | 15.2 | 16.7 | 30.4 | 33.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 28.6 | 32.8 | 35.7 | 62.6 | 65.3 |
Operating Profit | -4.03 | -5.1 | -4.35 | -6.65 | -5.86 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.48 | -2.71 | -6.25 | -6.39 | -2.68 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.33 | -2.52 | -6.02 | -5.91 | -2.76 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.33 | -2.52 | -6.02 | -5.91 | -2.76 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.33 | -2.52 | -6.02 | -5.91 | -2.76 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.05 | -0.028 | -0.105 | -0.085 | -0.041 |